Anastrozole

Anastrozole

Form: Oral Tablet

Strength: 1 mg

Reference Brands: Arimidex®(US & EU)

Category: Oncology Cancer Care

Anastrozole 1 mg Tablets are a key treatment in the management of hormone receptor-positive breast cancer. Available in both brand name (Arimidex®) and generic formulations, Anastrozole is used in adjuvant and metastatic settings for postmenopausal women. It works as a non-steroidal aromatase inhibitor, reducing estrogen production to slow or stop the growth of estrogen-dependent breast cancers. Anastrozole is widely available in both the U.S. and EU and is a core component of oncology B2B offerings in breast cancer therapies. With 1 mg tablets as the standard strength, it is a critical medication in global oncology markets.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Atezolizumab

Strength: 1200 mg/20 mL

Form: Intravenous infusion

Reference Brands: Tecentriq® (EU & US)

View Details Get Enquiry
Durvalumab

Strength: 120 mg/4 mL, 500 mg/10 mL

Form: Injection

Reference Brands: Imfinzi® (US & EU)

View Details Get Enquiry
Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details Get Enquiry
Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifex® (US), Holoxan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.